2054-3166

EMJ Respiratory

European Medical Group

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 195 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact195 DOIs
2

Add license metadata to 193 records

License metadata tells indexers and readers how each article may be reused.

High impact193 DOIs
3

Deposit reference lists for 52 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact52 DOIs

DOIs for this ISSN

Showing the top 5 of 197 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Effectiveness of Inhaler Devices in Adult Asthma and COPD (10.33590/emjrespir/10313608)
References ORCID License
85.96 13
2 Challenges of Inhaler Use in the Treatment of Asthma and Chr… (10.33590/emjrespir/10311052)
References ORCID License
75.00 9
3 Brief Clinical Review: Non-Responding Pneumonia (10.33590/emjrespir/10311091)
References ORCID License
71.57 8
4 Airway Clearance in the Intensive Care Unit (10.33590/emjrespir/10313713)
References ORCID License
67.73 7
5 Inhaled Ambient Particulate Matter and Lung Health Burden (10.33590/emjrespir/10314956)
References ORCID License
67.73 7
6 Influence of Air Pollution on Respiratory Disease (10.33590/emjrespir/10312112)
References ORCID License
58.36 5
7 Novel Insights Into Chronic Obstructive Pulmonary Disease (C… (10.33590/emjrespir/10312398)
References ORCID License
52.42 4
8 Long-Term Non-Invasive Ventilation (NIV) for COPD Patients w… (10.33590/emjrespir/10313501)
References ORCID License
52.42 4
9 Smoking Cessation with Lung Cancer: Not Too Little, Never To… (10.33590/emjrespir/10311510)
Abstract ORCID License
45.15 3
10 Alternative Exercise and Breathing Interventions in Chronic… (10.33590/emjrespir/10312774)
ORCID License
45.15 7
11 Managing Extubation and the Post Extubation Period in the In… (10.33590/emjrespir/10313378)
ORCID License
42.25 6
12 Nerves, Cough, and Idiopathic Pulmonary Fibrosis (10.33590/emjrespir/10312904)
ORCID License
38.91 5
13 A Patient Perspective: Identifying and Understanding the Bar… (10.33590/emjrespir/10314298)
ORCID License
38.91 5
14 ‘No Stent Left Behind’: A Review of Stent Removal and Relate… (10.33590/emjrespir/10314389)
ORCID License
38.91 5
15 Bronchoscopic Nitinol Coil Implantation: A New Lung Volume R… (10.33590/emjrespir/10310498)
References ORCID License
35.78 2
16 Loose ENDs: Electronic Nicotine Delivery Systems and the FDA… (10.33590/emjrespir/20-00161)
Abstract ORCID License
35.78 2
17 Thymomas and Thymic Carcinomas: A Review on Pathology, Prese… (10.33590/emjrespir/10310358)
ORCID License
34.95 4
18 Review of the European Respiratory Society (ERS) Internation… (10.33590/emjrespir/10304133)
Abstract References ORCID License
30.10 1
19 Therapeutic Effect of Whole Lung Lavage on Pneumoconiosis (10.33590/emjrespir/10311749)
ORCID License
30.10 3
20 Asthma in Children Under 5 Years in Rural Kyrgyzstan: A Diag… (10.33590/emjrespir/10314133)
ORCID License
30.10 3
21 Proactive Risk Management: A Novel Approach to Embedding Ora… (10.33590/emjrespir/10088956)
ORCID License
23.86 2
22 Chronic Obstructive Pulmonary Disease: Biofilm Mediated Exac… (10.33590/emjrespir/10305099)
ORCID License
23.86 2
23 Electronic Cigarette Use Among Emerging and Young West India… (10.33590/emjrespir/10310313)
ORCID License
23.86 2
24 Non-Intubated Video-Assisted Thoracic Surgery from Multi to… (10.33590/emjrespir/10312090)
ORCID License
23.86 2
25 Noninvasive Ventilation: Challenges and Pitfalls (10.33590/emjrespir/10312141)
ORCID License
23.86 2
26 Massive Alveolar Haemorrhage Presenting During the COVID-19… (10.33590/emjrespir/20-00267)
ORCID License
23.86 2
27 Information and Communication Technology in the Fight Agains… (10.33590/emjinnov/20-00220)
Abstract ORCID License
22.58 1
28 Deep Learning-Based Quantification of Traction Bronchiectasi… (10.33590/emjrespir/10307156)
Abstract ORCID License
22.58 1
29 Rationale for Endobronchial Coil Treatment as the Primary In… (10.33590/emjrespir/10310010)
References ORCID License
22.58 1
30 New Options for Optimal Bronchodilation in Chronic Obstructi… (10.33590/emjrespir/10310221)
References ORCID License
22.58 1
31 Novel Treatment Options for Autoimmune Pulmonary Alveolar Pr… (10.33590/emjrespir/10311568)
References ORCID License
22.58 1
32 Precision Strikes: Personalising Potentially Surgically Rese… (10.33590/emjrespir/hsmb8410)
Abstract ORCID License
22.58 1
33 Inhalation Innovation: Phase IIb Study Design of Inhaled Pir… (10.33590/emjrespir/mxjy9650)
Abstract ORCID License
22.58 1
34 Effect of 8-Week Exercise-Based Rehabilitation on Immune Cel… (10.33590/emjrespir/ygpk7634)
Abstract ORCID License
22.58 1
35 New Frontiers in Chronic Obstructive Pulmonary Disease: Wher… (10.33590/emjrespir/10038710)
ORCID License
15.05 1
36 Efficiency Assessment of 15 Nebuliser Systems by the Respira… (10.33590/emjrespir/10303785)
ORCID License
15.05 1
37 Prioritising Patient Outcomes and Reducing Environmental Bur… (10.33590/emjrespir/10305679)
ORCID License
15.05 1
38 A Case of Empyema and a Review of Practice in a District Gen… (10.33590/emjrespir/10311094)
ORCID License
15.05 1
39 Chronic Obstructive Pulmonary Disease and Arterial Stiffness (10.33590/emjrespir/10311249)
ORCID License
15.05 1
40 Anti-Programmed Death Receptor 1 Signalling Immunotherapy as… (10.33590/emjrespir/10311519)
ORCID License
15.05 1
41 Established Statin Use Reduces Mortality From Community-Acqu… (10.33590/emjrespir/10311855)
ORCID License
15.05 1
42 Respiratory Symptoms, Lung Function Impairment, and Chronic… (10.33590/emjrespir/10312773)
ORCID License
15.05 1
43 Allergen Challenge Testing in Atopic Asthma Pharmaceutical R… (10.33590/emjrespir/10313205)
ORCID License
15.05 1
44 Advances in the Diagnosis of HIV-Associated Tuberculosis (10.33590/emjrespir/10313482)
ORCID License
15.05 1
45 Improving Antenatal Asthma Management: A Complex Journey (10.33590/emjrespir/20-00143)
ORCID License
15.05 1
46 Risk Factors for Severe Coronavirus Disease (COVID-19) (10.33590/emjrespir/20-00151)
ORCID License
15.05 1
47 Post-COVID-19 Pulmonary Fibrosis: Report of Two Cases (10.33590/emjrespir/20-00270)
ORCID License
15.05 1
48 Epstein–Barr Virus-Induced Acute Hepatitis, Pancreatitis, an… (10.33590/emjrespir/21-00050)
ORCID License
15.05 1
49 Pulmonary Embolism in Vaccine-Induced Thrombotic Thrombocyto… (10.33590/emjrespir/21-00160)
ORCID License
15.05 1
50 Understanding the Under-Recognised Burden and Unmet Needs in… (10.33590/10.33590/emjrespir/10308334)
ORCID License
0.00 0